Form 4: BioLife Solutions EVP Aby J. Mathew Sells Shares to Cover Tax Obligations

Aby J. Mathew, EVP & Chief Scientific Officer of BioLife Solutions Inc., sold 10,589 shares of common stock on April 1, 2025, to cover tax withholding obligations.

Summary

• On April 1, 2025, Aby J. Mathew, the EVP & Chief Scientific Officer of BioLife Solutions Inc. (BLFS), sold 10,589 shares of common stock.
• The sale was executed at a price of $22.66 per share.
• The transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by Mathew on January 3, 2023.
• The purpose of the sale was to satisfy tax withholding obligations related to the vesting of restricted stock shares.
• Following the transaction, Mathew directly owns 309,576 shares of BioLife Solutions Inc.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale of shares for tax purposes under a pre-existing trading plan. It doesn't indicate a change in the executive's confidence in the company.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity. It is common for executives to sell shares to cover tax obligations related to stock vesting. The Rule 10b5-1 plan allows insiders to trade without being accused of acting on non-public information.

Stakeholder Impact

• The sale of shares by an executive could have a minor negative impact on shareholder sentiment, but the impact is likely to be minimal since it was pre-planned and for tax purposes.

Key Dates

Keywords

BioLife Solutions, BLFS, Aby J. Mathew, insider trading, Form 4, stock sale, Rule 10b5-1, tax obligations, restricted stock, EVP, Chief Scientific Officer